Home > About us > Overview
Samyang's Pharmaceutical Business Units
Samyang's Pharmaceutical Business Unit, in collaboration with Samyang's central
research center, is engaged in the development and marketing of novel drug
delivery systems and medical devices.

Samyang is focusing its efforts on healthcare as its core strategic business
for the 21st century. Samyang is developing proprietary and unique core
technologies for the development of world class novel drug delivery systems.

In 1996 the company completed construction of its ultra modern,
KGMP-approved pharmaceutical formulation plant in Taeduk and started business
activity with several transdermal patches.
Daeduk Pharmceutical & Medical Devices Plant
DaeDuk Pharmaceutical & Medical Devices Plant is an up-to-date
manufacturing facility equipped to produce novel DDS formulations
and medical devices.
The plant was established in July 1996, and approved KGMP
manufacturer in November 1996. The plant also gained ISO9001
accredition in August 1999.
Samyang's Pharmaceuticals R&D Center
The Samyang Pharmaceuticals R&D Center aims to become world class
research center for research in drug delivery systems.
Utilizing many experiences and know-how within the Samyang group
in the field of polymer chemistry and fine chemicals and also with a close collaboration with international partners, the center is making rapid
progress in developing several innovative dosage forms to deliver drugs more conveniently, efficiently and accurately.
Copyright 2005 by Samyang Corporation. All rights reserved.